Apr 04, 2018

Fagron Strengthens Strategic Position in USA Through Highly Complementary Acquisition of Humco

Fagron announces today the acquisition of Humco, a leading developer, manufacturer and supplier of patented delivery vehicles and branded pharmaceutical products to over 45,000 pharmacies in the USA. The acquisition price for Humco amounts to US$ 47.5 million (approximately € 38.6 million) in cash, with the potential for a performance linked earn-out of up to US$ 22.5 million (approximately € 18.3 million) in cash over a two-year period. The total consideration for the acquisition of Humco is thus capped at US$ 70.0 million (approximately € 56.9 million). The transaction includes all technologies, scientific data, patents and trademarks, as well as the production facility of Humco in Texas (USA).

Humco, founded in 1872 as Hutchison Medicine Company, realized a turnover of approximately US$ 32 million (approximately € 26 million) and an EBITDA-margin in line with that of the activities of Fagron North-America in 2017. The company is focused on developing, manufacturing and commercializing innovative patented delivery vehicles (including topical and transdermal creams, syrups and suspensions) and branded pharmaceutical products that are cash-paid by the customer (not reimbursed). In 2016, Humco added a limited portfolio of active pharmaceutical ingredients to its product offer. Humco serves over 45,000 pharmacies in the USA, mainly indirectly through pharmacy chains and wholesalers. Humco is located in Austin (Texas, USA) and has a state-of-the-art FDA registered, cGMP compliant production facility in Texarkana (Texas, USA). All 140 employees from Humco join Fagron, bringing expertise to innovate and serve an expanded customer base worldwide.

"I am pleased to welcome Humco to Fagron Group. Their high-quality portfolio of branded pharmaceutical products and widely used patented delivery vehicles that are supplied to a broad customer base of pharmacy chains and wholesalers in the USA is highly complementary to our extensive range of active pharmaceutical ingredients. Humco is an excellent strategic fit for Fagron. By combining the two companies, we create a strong competitive company with significant scale, strengthening our market position in the USA. Our global footprint and leading market positions in Europe and South-America will enable us to successfully launch and grow the innovative branded pharmaceutical products and delivery vehicles of Humco outside the USA. We look forward to welcome the Humco employees to the Fagron family," said Rafael Padilla, Fagron's CEO.

Following the transaction, Gregory Pulido, Humco's Chairman and CEO, will transition to the role of Executive Chairman while Andrew Pulido, Humco's current President, Global Pharmaceuticals, will assume the sole role of President at Humco.

"We are delighted and proud to become part of the Fagron Group. Being part of a large global organization and a world leader in pharmaceutical compounding creates a more capable and dynamic company for our customers and employees. We complement each other, selling in adjacent markets with very little customer overlap, enabling a significant number of growth opportunities. While we introduce our successful and unique patented delivery vehicles and branded pharmaceutical products internationally, our customers can benefit from the excellent range of more than 1,600 high quality active pharmaceutical ingredients of Fagron," said Gregory Pulido.

Andrew Pulido said, "I am honored to become Humco's President at such an exciting time. The joint activities of Fagron and Humco are extremely well positioned to capitalize on growth opportunities in the USA and around the world. I am confident that our expertise, creativity and dedication will enable us to offer increased value to our customers, suppliers and employees as well as to further extend Fagron's leadership in the market for personalized medication."

Market Buzz

Jan 16, 2019 Helmer Scientific Launches the First Professional Medical-grade Refrigerators
Jan 15, 2019 The Compliance Team™ celebrates 25 years of accreditation transformation
Jan 11, 2019 CORE Higher Education Group partners with Pharmacists Mutual
Jan 08, 2019 Tutela Welcomes the Center for Organ Recovery and Education
Dec 13, 2018 PharmaLink Launches Updated Website
Dec 11, 2018 Jorgenson Issues Annual List of Major Challenges Facing Hospital and Health Syst...
Nov 29, 2018 BD Expands Integrated Medication Management to Help Tackle Hospital Drug Diversi...
Nov 13, 2018 Akro-Mils 2019 Catalog
Nov 13, 2018 New Data Shows Many Health System Pharmacies Considering Consolidated Distributi...
Oct 17, 2018 Retail Management Solutions Celebrates 20 Years of Pharmacy POS Innovation
Oct 17, 2018 Hardy Diagnostics Releases a New Locking Lid Feature for all Contact Plates
Oct 15, 2018 Transaction Data Systems Partners with Community Pharmacies to Fight the Opioid ...
Oct 12, 2018 1st Patient-Centered Respiratory Home™ Accreditation Recipient Named
Oct 10, 2018 Augusta University Health Selects Omnicell’s Industry-Leading Medication Manag...
Oct 04, 2018 QS/1® Honors Pharmacists at NCPA
Oct 03, 2018 Innovation to Move to New Campus in New York’s Southern Tier to Accommodate St...
Oct 03, 2018 Equashield and Max Care Medical to Distribute Leading Closed System Transfer Dev...
Oct 01, 2018 Global Needlefree Closed System Transfer Device (CSTD) Market 2018 by Manufactur...
Sep 23, 2018 Prudential Overall Supply Celebrates Dan Clark's 50th Employment Anniversary
Sep 19, 2018 RXQ Compounding Expanding in Albany
Sep 17, 2018 Middlesex Hospital Bolsters Pharmacy Safety and Compliance by Extending Wolters ...
Sep 14, 2018 Synergy Medical once again among Canada's Top 500 Companies
Sep 10, 2018 American Associated Pharmacies Taps FDS to Bring its Members a State-of-the-Art ...
Sep 10, 2018 Rees Scientific achieved ISO/IEC 17025:2017 Accreditation
Sep 06, 2018 Medical Packaging Inc. Named One of The Best Places to Work In New Jersey
Sep 06, 2018 Americorp Financial Launches New Brand, Website for Equipment Financing
Sep 04, 2018 Excelera® Specialty Pharmacy Network Announces Partnership with Smith & Nephew
Aug 30, 2018 Letco Medical, L.L.C. Announces Exclusive Partnership with Sweetgrass GxP Group,...
Aug 29, 2018 QS/1® Selected as Early Adopter in New CMS SCRIPT Standard
Aug 23, 2018 Innovations to Omnicell Patient Engagement Platform Support Value-Based, Patient...

RXinsider Product Overview Videos